Conversely, individuals with higher baseline body mass or strong family history of obesity may require higher doses to sustain meaningful weight loss, though this requires provider oversight and biomarker monitoring
Ann Intern Med 173:278286 Overgaard RV, Navarria A, Ingwersen SH, Bkdal TA, Kildemoes RJ (2021) Clinical pharmacokinetics of oral semaglutide: analyses of data from clinical Pharmacology trials
For some patients, peptide therapy may be considered alongside other services at Conscious Health, including NAD+ therapy, mental health treatment, TMS, ketamine-assisted therapy, nutritional support, and integrative wellness planning
I am in rheumatology and pain management and we consistently see reduced joint pain and inflammation in patients on GLP one medications long before they are losing substantial amounts of weight indicating the probability of a secondary anti-inflammatory effect